EPCT-09. CLR 131 IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC MALIGNANCIES

BACKGROUND: CLR 131 is a novel targeted radiotherapeutic that exploits the selective uptake and retention of phospholipid ethers by malignant cells. CLR 131 selectively delivers radiation to malignant tumor cells, thus minimizing radiation exposure to normal tissues. OBJECTIVE: CLR 131 is being exam...

Descripción completa

Detalles Bibliográficos
Autores principales: Puccetti, Diane, Otto, Mario, Morgenstern, Daniel, DeSantes, Kenneth, Cho, Steven, Hall, Lance, Oliver, Kate, Longcor, Jarrod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Early Phase Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715900/
http://dx.doi.org/10.1093/neuonc/noaa222.133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715900/
http://dx.doi.org/10.1093/neuonc/noaa222.133

Ejemplares similares